3,325
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Factors influencing abortion decisions, delays, and experiences with abortion accompaniment in Mexico among women living outside Mexico City: results from a cross-sectional study

ORCID Icon, , , , &

References

  • Becker D, Díaz Olavarrieta C. Decriminalization of abortion in Mexico City: the effects on women’s reproductive rights. Am J Public Health. 2013;103:590–593.
  • Hidalgo becomes third Mexican state to allow abortion Reuters. [Cited 2 July 2021]. Available from: https://www.reuters.com/world/americas/hidalgo-becomes-third-mexican-state-allow-abortion-2021-06-30/.
  • Kitroeff N, Lopez O. Abortion is no longer a crime in Mexico. But will doctors object? The New York Times. 13 September 2021. [Cited 20 September 2021]. Available from: https://www.nytimes.com/2021/09/13/world/americas/mexico-abortion-objectors.html.
  • El aborto en los códigos penales. Gire. [Cited 20 September 2021]. Available from: https://gire.org.mx/plataforma/causales-de-aborto-en-codigos-penales/.
  • Fact Sheet. Causales Legales Para El Aborto [Internet]. Ipas Mexico, 2019.
  • Küng SA, Darney BG, Saavedra-Avendaño B, et al. Access to abortion under the heath exception: a comparative analysis in three countries. Reprod Health. 2018;15:107.
  • Becker D, Diaz-Olavarrieta C, Juarez C, et al. Sociodemographic factors associated with obstacles to abortion care: findings from a survey of abortion patients in Mexico City. Womens Health Issues Off Publ Jacobs Inst Womens Health. 2011;21:S16–S20.
  • Lamas M. Entre el estigma y la ley: la interrupción legal del embarazo en el DF. Salud Pública México. 2014;56:56–62.
  • Krauss A. Luisa’s ghosts: haunted legality and collective expressions of pain. Med Anthropol. 2018;37:688–702.
  • Sorhaindo AM, Juárez-Ramírez C, Olavarrieta CD, et al. Qualitative evidence on abortion stigma from Mexico City and five states in Mexico. Women Health. 2014;54:622–640.
  • Narasimhan M, Logie CH, Gauntley A, et al. Self-care interventions for sexual and reproductive health and rights for advancing universal health coverage. Sex Reprod Health Matters. 2020;28:1778610.
  • Drovetta RI. Safe abortion information hotlines: An effective strategy for increasing women’s access to safe abortions in Latin America. Reprod Health Matters. 2015;23:47–57.
  • Gerdts C, Hudaya I. Quality of care in a safe-abortion hotline in Indonesia: beyond harm reduction. Am J Public Health. 2016;106:2071–2075.
  • Erdman JN, Jelinska K, Yanow S. Understandings of self-managed abortion as health inequity, harm reduction and social change. Reprod Health Matters. 2018;26:13–19.
  • Fondo MARIA. Fondo Maria. [Cited 23 June 2021]. Available from: https://www.fondomaria.org/.
  • Centro Nacional de Equidad de Género y Salud Reproductiva. Técnico para la atención del Aborto Seguro en México. 14 June 2021.
  • Miller S, Lehman T, Campbell M, et al. Misoprostol and declining abortion-related morbidity in Santo Domingo. Dominican Republic: a temporal association. BJOG Int J Obstet Gynaecol. 2005;112:1291–1296.
  • Zurbriggen R, Keefe-Oates B, Gerdts C. Accompaniment of second-trimester abortions: the model of the feminist Socorrista network of Argentina. Contraception. 2018;97:108–115.
  • Lafaurie MM, Grossman D, Troncoso E, et al. Women’s perspectives on medical abortion in Mexico, Colombia, Ecuador and Peru: a qualitative study. Reprod Health Matters. 2005;13:75–83.
  • Dzuba IG, Winikoff B, Peña M. Medical abortion: a path to safe, high-quality abortion care in Latin America and the Caribbean. Eur J Contracept Reprod Health Care. 2013;18:441–450.
  • Gerdts C, Jayaweera RT, Baum SE, et al. Second-trimester medication abortion outside the clinic setting: an analysis of electronic client records from a safe abortion hotline in Indonesia. BMJ Sex Reprod Health. 2018;44:286–291.
  • Zamberlin N, Romero M, Ramos S. Latin American women’s experiences with medical abortion in settings where abortion is legally restricted. Reprod Health. 2012;9:34.
  • Upadhyay UD, Dworkin SL, Weitz TA, et al. Development and validation of a reproductive autonomy scale. Stud Fam Plann. 2014;45:19–41.
  • Moseson H, Bullard KA, Cisternas C, et al. Effectiveness of self-managed medication abortion between 13 and 24 weeks gestation: a retrospective review of case records from accompaniment groups in Argentina, Chile, and Ecuador. Contraception.
  • Grossman D, Baum SE, Andjelic D, et al. A harm-reduction model of abortion counseling about misoprostol use in Peru with telephone and in-person follow-up: a cohort study. PloS One; 13.
  • Gerdts C, Jayaweera RT, Kristianingrum IA, et al. Effect of a smartphone intervention on self-managed medication abortion experiences among safe-abortion hotline clients in Indonesia: a randomized controlled trial. Int J Gynecol Obstet. 2020;149:48–55.
  • Jelinska K, Yanow S. Putting abortion pills into women’s hands: realizing the full potential of medical abortion. Contraception. 2018;97:86–89.
  • De Zordo S, Zanini G, Mishtal J, et al. Gestational age limits for abortion and cross-border reproductive care in Europe: a mixed-methods study. BJOG Int J Obstet Gynaecol.
  • Makleff S, Labandera A, Chiribao F, et al. Experience obtaining legal abortion in Uruguay: knowledge, attitudes, and stigma among abortion clients. BMC Womens Health. 2019;19:155.
  • Cockrill K, Upadhyay UD, Turan J, et al. The stigma of having an abortion: development of a scale and characteristics of women experiencing abortion stigma. Perspect Sex Reprod Health. 2013;45:79–88.
  • Foster DG, Jackson RA, Cosby K, et al. Predictors of delay in each step leading to an abortion. Contraception. 2008;77:289–293.
  • Proyecciones de la Población 2010-2050. Consejo Nacional de Población CONAPO. [Cited 15 June 2018]. Available from: http://www.conapo.gob.mx/es/CONAPO/proyecciones.
  • Bercu C, Fillipa S, Ramirez AM, et al. Perspectives on interpersonal care among people who obtain abortions through clinical and accompaniment models in Argentina. Epub ahead of print 23 September 2021. DOI:10.21203/rs.3.rs-391415/v1.
  • Tousaw E, Moo SNHG, Arnott G, et al. “It is just like having a period with back pain”: exploring women’s experiences with community-based distribution of misoprostol for early abortion on the Thailand–Burma border. Contraception. 2018;97:122–129.
  • Brown RW, Jewell RT, Rous JJ. Provider availability, race, and abortion demand. South Econ J. 2001: 656–671.
  • Aiken AR, Gomperts R, Trussell J. Experiences and characteristics of women seeking and completing at-home medical termination of pregnancy through online telemedicine in Ireland and Northern Ireland: a population-based analysis. BJOG Int J Obstet Gynaecol. 2017;124:1208–1215.
  • Foster DG, Kimport K. Who seeks abortions at or after 20 weeks? Perspect Sex Reprod Health. 2013;45:210–218.
  • Grossman D, Garcia SG, Kingston J, et al. Mexican women seeking safe abortion services in San Diego, California. Health Care Women Int. 2012;33:1060–1069.
  • Karasek D, Roberts SC, Weitz TA. Abortion patients’ experience and perceptions of waiting periods: survey evidence before Arizona’s two-visit 24-hour mandatory waiting period law. Womens Health Issues. 2016;26:60–66.
  • Upadhyay UD, Weitz TA, Jones RK, et al. Denial of abortion because of provider gestational age limits in the United States. Am J Public Health. 2014;104:1687–1694.
  • Saavedra-Avendano B, Schiavon R, Sanhueza P, et al. Who presents past the gestational age limit for first trimester abortion in the public sector in Mexico City? PloS One. 2018;13:e0192547.
  • Conti J, Cahill EP. Self-managed abortion. Curr Opin Obstet Gynecol. 2019;31:435–440.
  • Ngo TD, Park MH, Shakur H, et al. Comparative effectiveness, safety and acceptability of medical abortion at home and in a clinic: a systematic review. Bull World Health Organ. 2011;89:360–370.
  • Aiken AR, Digol I, Trussell J, et al. Self reported outcomes and adverse events after medical abortion through online telemedicine: population based study in the Republic of Ireland and Northern Ireland. Br Med J; 357.
  • Foster AM, Arnott G, Hobstetter M. Community-based distribution of misoprostol for early abortion: evaluation of a program along the Thailand–Burma border. Contraception. 2017;96:242–247.
  • Keefe-Oates B, Makleff S, Sa E, et al. Experiences with abortion counselling in Mexico City and Colombia: addressing women’s fears and concerns. Cult Health Sex. 2020;22:413–428.
  • Juarez F, Bankole A, Palma JL. Women’s abortion seeking behavior under restrictive abortion laws in Mexico. PLOS ONE. 2019;14:e0226522.
  • Mexico to restrict mobility to areas less affected by virus. AP NEWS. [Cited 29 June 2021]. Available from: https://apnews.com/article/9e5bb61c8bb22aba3fe0557aa82f592e. 2020.
  • Hanschmidt F, Linde K, Hilbert A, et al. Abortion stigma: a systematic review. Perspect Sex Reprod Health. 2016;48:169–177.
  • McMurtrie SM, García SG, Wilson KS, et al. Public opinion about abortion-related stigma among Mexican Catholics and implications for unsafe abortion. Int J Gynecol Obstet. 2012;118:S160–S166.
  • Cockrill K, Nack A. “I’m not that type of person”: managing the stigma of having an abortion. Deviant Behav. 2013;34:973–990.
  • Moseson H, Herold S, Filippa S, et al. Self-managed abortion: a systematic scoping review. Best Pract Res Clin Obstet Gynaecol. 2020;63:87–110.
  • Aiken ARA, Starling JE, Gomperts R. Factors associated with use of an online telemedicine service to access self-managed medical abortion in the US. JAMA Netw Open. 2021;4:e2111852.
  • Aiken ARA, Broussard K, Johnson DM, et al. Motivations and experiences of people seeking medication abortion online in the United States. Perspect Sex Reprod Health. 2018;50:157–163.
  • Senderowicz L, Sanhueza P, Langer A. Education, place of residence and utilization of legal abortion services in Mexico City, 2013–2015. Int Perspect Sex Reprod Health. 2018;44:43–50.
  • Jacobson LE, Saavedra-Avendano B, Fuentes-Rivera E, et al. Travelling for abortion services in Mexico 2016–2019: community-level contexts of Mexico City public abortion clients. BMJ Sex Reprod Health. Epub ahead of print. 28 July 2021. DOI:10.1136/bmjsrh-2021-201079.
  • Darney BG, Fuentes-Rivera E, Saavedra-Avendaño B, et al. Contraceptive receipt among first-trimester abortion clients and postpartum women in urban Mexico. Int Perspect Sex Reprod Health. 2020;46:35–43.
  • Olavarrieta CD, Garcia SG, Arangure A, et al. Women’s experiences of and perspectives on abortion at public facilities in Mexico City three years following decriminalization. Int J Gynecol Obstet. 2012;118:S15–S20.
  • Becker D, Díaz-Olavarrieta C, Juárez C, et al. Clients’ perceptions of the quality of care in Mexico City’s public-sector legal abortion program. Int Perspect Sex Reprod Health. 2011;37:191.
  • McLemore MR, Desai S, Freedman L, et al. Women know best – findings from a thematic analysis of 5,214 surveys of abortion care experience. Women39s Health Issues; 24:594–599.
  • Taylor D, Postlethwaite D, Desai S, et al. Multiple determinants of the abortion care experience: from the patient’s perspective. Am J Med Qual. 2013;28:510–518.
  • McLemore MR, Desai S, James EA, et al. Letter to the editor, re: article “factors influencing women’s satisfaction with surgical abortion” by Tilles, Denny, Cansino and Creinin. Contraception. 2016;93:372.
  • Wollum A, Garnsey C, Baum S, et al. El acceso al aborto y su impacto en las nociones de estigma para las mujeres: evaluación del modelo de acompañamiento del Fondo de Aborto para Justicia Social. Ibis Reproductive Health. In Press.
  • Sudhinaraset M, Afulani P, Diamond-Smith N, et al. Advancing a conceptual model to improve maternal health quality: the person-centered care framework for reproductive health equity. Gates Open Res; 1.
  • Altshuler AL, Whaley NS. The patient perspective: perceptions of the quality of the abortion experience. Curr Opin Obstet Gynecol. 2018;30:407–413.